LOWER: Lomitapide Observational Worldwide Evaluation Registry

Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Lomitapide in Healthy Subjects.

NCT02080455 ·Status: COMPLETED ·Phase: PHASE1

Phase I Study of the Safety, Tolerability, PK & PD of Lomitapide in Japanese and Caucasian Subjects With Elevated LDL-C

NCT01760187 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability and Efficacy of Microsomal Triglyceride Protein (MTP) Inhibitor

NCT01556906 ·Status: COMPLETED ·Phase: PHASE2

An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia

NCT00694109 ·Status: COMPLETED ·Phase: PHASE3

Implitapide in Patients With Homozygous Familial Hypercholesterolemia (HoFH) on Maximal Concurrent Lipid-Lowering Therapy

NCT00079846 ·Status: TERMINATED ·Phase: PHASE2

A Study of LY3015014 in Healthy Participants With High Cholesterol

NCT01671085 ·Status: COMPLETED ·Phase: PHASE1

A Study of LY3015014 in Participants With High Cholesterol

NCT01890967 ·Status: COMPLETED ·Phase: PHASE2

Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy

NCT00079859 ·Status: TERMINATED ·Phase: PHASE2

A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin

NCT00530946 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042)

NCT01841684 ·Status: TERMINATED ·Phase: PHASE3

Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia

NCT00477594 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Efficacy of Two Different Regimens of Mipomersen in Patients With Familial Hypercholesterolemia and Inadequately Controlled Low-Density Lipoprotein Cholesterol

NCT01475825 ·Status: COMPLETED ·Phase: PHASE3

Education and Awareness Program Targeting the Assessment of Adherence of the Treatment of Dyslipidemia

NCT00557778 ·Status: COMPLETED

Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins

NCT01859455 ·Status: COMPLETED ·Phase: PHASE1

To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients

NCT06866509 ·Status: COMPLETED

LY2189265 and Atorvastatin Interaction Study

NCT01250834 ·Status: COMPLETED ·Phase: PHASE1

Long-Term Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia

NCT00325780 ·Status: COMPLETED ·Phase: PHASE3

Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders

NCT01624142 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)

NCT00723723 ·Status: COMPLETED

A Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-040XC, in Healthy Male Subjects

NCT01806324 ·Status: COMPLETED ·Phase: PHASE1

Safety FollowUp Study Of Cardiovascular Events In Subjects Who Participated In Selected Torcetrapib/Atorvastatin Studies

NCT00452842 ·Status: TERMINATED

Evaluate the Pharmacokinetics and Safety of HCP1306 and Co-administration of HGP0816, HGP1404 in Healthy Male Volunteers

NCT02941848 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Study of ISIS 301012 (Mipomersen) Administration in High Risk Statin Intolerant Subjects

NCT00707746 ·Status: COMPLETED ·Phase: PHASE2

Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin

NCT00309738 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia

NCT04455581 ·Status: UNKNOWN ·Phase: PHASE2